title: [The effect of intravenous ciprofloxacin for community acquired pneumonia in adults].
abstract: To verify the indication of intravenous fluoroquinolone in guideline for treatment of community-acquired pneumonia published in Japanese Respiratory Society, the effect of intravenous ciprofloxacin was investigated in this study. 49 cases of community-acquired pneumonia were treated by intravenous ciprofloxacin. Total response rate was 77.1%. 66.7% of response rate was achieved even in the cases which other antibiotics had been already introduced and failed. The data of this study indicated that intravenous ciprofloxacin was one of the effective and appropriate therapeutics for community-acquired pneumonia in adults.
authors.affiliation: Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu Univiersity.
authors.forename: Masaki
authors.initials: M
authors.lastname: Fujita
authors.forename: Tsuneo
authors.initials: T
authors.lastname: Ishibashi
authors.forename: Nobuyuki
authors.initials: N
authors.lastname: Hara
authors.forename: Minoru
authors.initials: M
authors.lastname: Yoshida
authors.forename: Hozumi
authors.initials: H
authors.lastname: Yamada
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D002939:Ciprofloxacin / Q000627:therapeutic use*; D017714:Community-Acquired Infections / Q000188:drug therapy*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D018410:Pneumonia, Bacterial / Q000188:drug therapy*
chemical_list: D000890:Anti-Infective Agents; D002939:Ciprofloxacin